Literature DB >> 10922281

Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values.

M Wong1, B L Schlaggar, R S Buller, G A Storch, M Landt.   

Abstract

OBJECTIVES: To define clinically relevant reference ("normal") values for cerebrospinal fluid (CSF) protein concentrations in pediatric patients who were evaluated for meningitis by traditional criteria and by enterovirus-polymerase chain reaction (EV-PCR). DESIGN AND PATIENTS: A cohort of 906 consecutive pediatric patients to receive CSF analysis at St Louis Children's Hospital, St Louis, Mo, from June 1, 1998, to December 31,1998, was studied for clinical and laboratory data. Age-dependent CSF protein concentrations were then derived from a reference group of 225 patients in whom meningitis and other neurologic diseases were excluded by traditional clinical or laboratory criteria (excluding EV-PCR). Available CSF samples from 132 patients of the reference group were subsequently tested for EV-PCR.
RESULTS: In the reference group, the CSF protein concentration was highest and most variable in neonates, with a maximum of approximately 1.0 g/L. Cerebrospinal fluid protein concentration decreased rapidly to a nadir by 6 months and remained low throughout childhood, rarely exceeding 0.3 g/L and, finally, increasing in adolescence toward adult values. Enterovirus- polymerase chain reaction was positive in CSF of 11% of the reference group, with EV-PCR-positive patients having significantly higher CSF protein concentrations than EV-PCR-negative patients aged between 4 months and 14 years.
CONCLUSIONS: Reference values for CSF protein exhibit a characteristic age dependence in pediatric patients. Continued standard use of adult reference values in the pediatric population is inappropriate. The unexpected finding of a positive EV-PCR in patients not diagnosed with meningitis by traditional criteria further emphasizes the importance of selecting the most clinically relevant reference group for age and other variables when defining normal laboratory values. Arch Pediatr Adolesc Med. 2000;154:827-831

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922281     DOI: 10.1001/archpedi.154.8.827

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  10 in total

1.  New reverse transcription-PCR assay for rapid and sensitive detection of enterovirus genomes in cerebrospinal fluid specimens of patients with aseptic meningitis.

Authors:  Jérôme Jacques; Jocelyne Carquin; Véronique Brodard; Hélène Moret; Dorine Lebrun; Maude Bouscambert; Jacques Motte; Gérard Rémy; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients.

Authors:  William S Mulford; Richard S Buller; Max Q Arens; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Total protein is an effective loading control for cerebrospinal fluid western blots.

Authors:  Mahlon A Collins; Jiyan An; Danielle Peller; Robert Bowser
Journal:  J Neurosci Methods       Date:  2015-05-22       Impact factor: 2.390

4.  Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants.

Authors:  Samir S Shah; Jessica Ebberson; Lori A Kestenbaum; Richard L Hodinka; Joseph J Zorc
Journal:  J Hosp Med       Date:  2010-07-13       Impact factor: 2.960

5.  Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry.

Authors:  Robert Cunningham; Paige Jany; Albee Messing; Lingjun Li
Journal:  J Proteome Res       Date:  2013-01-11       Impact factor: 4.466

6.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

7.  Age-specific reference values for cerebrospinal fluid protein concentrations in children in southern China.

Authors:  Zhigang Liu; Deqin Jia; Jieming Dai; Xing Zhou; Zhoulian Qin; Liang Chen; Jieyan Zhang; Guohua Chen; Xiaocheng He; Ruipin Wan; Xingguang Ye
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

8.  Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients.

Authors:  Armin Sebastian Guntner; Andreas Peyrl; Lisa Mayr; Bernhard Englinger; Walter Berger; Irene Slavc; Wolfgang Buchberger; Johannes Gojo
Journal:  Acta Neuropathol Commun       Date:  2020-06-03       Impact factor: 7.801

9.  Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.

Authors:  Sven Jarius; Christian Lechner; Eva M Wendel; Matthias Baumann; Markus Breu; Mareike Schimmel; Michael Karenfort; Adela Della Marina; Andreas Merkenschlager; Charlotte Thiels; Astrid Blaschek; Michela Salandin; Steffen Leiz; Frank Leypoldt; Alexander Pschibul; Annette Hackenberg; Andreas Hahn; Steffen Syrbe; Jurgis Strautmanis; Martin Häusler; Peter Krieg; Astrid Eisenkölbl; Johannes Stoffels; Matthias Eckenweiler; Ilya Ayzenberg; Jürgen Haas; Romana Höftberger; Ingo Kleiter; Mirjam Korporal-Kuhnke; Marius Ringelstein; Klemens Ruprecht; Nadja Siebert; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann; Kevin Rostásy
Journal:  J Neuroinflammation       Date:  2020-09-03       Impact factor: 8.322

10.  Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice.

Authors:  Wilhelmina G Leen; Michèl A Willemsen; Ron A Wevers; Marcel M Verbeek
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.